Analyst consensus rating
SpyGlass Pharma Analyst Rating: Strong Buy
Direct answer
SpyGlass Pharma's consensus rating is Strong Buy.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $46.67.
Forecast evidence checked November 17, 2026.
Get free SpyGlass Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $32.24
- Average price target
- $46.67
- High price target
- $62.00
- Low price target
- $42.00
- Low target gap
- +30.3%
- Target upside
- +44.7%
- High target gap
- +92.3%
- Target range width
- 62%
- Consensus rating
- Strong Buy
- Analysts
- 6
- Evidence date
- November 17, 2026
- Valid through
- November 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for SpyGlass Pharma?
SpyGlass Pharma has a verified Strong Buy consensus. The same dataset has an average price target of $46.67.
How far are SpyGlass Pharma's low and high targets from the recorded price?
The low target implies +30.3%, while the high target implies +92.3%.
How many analysts are included in SpyGlass Pharma's consensus?
The verified consensus includes 6 analysts.
How is SpyGlass Pharma's target upside or downside calculated?
The average target of $46.67 is divided by the recorded price of $32.24, then one is subtracted to produce +44.7%. This does not guarantee a future return.
When was SpyGlass Pharma's analyst forecast verified?
The data was verified on 2026-11-17. The dataset is valid through 2026-11-24.